IgG Fc engineering to modulate antibody effector functions.
Wang X, Mathieu M, Brezski RJ. · 2018
Read IgG Fc engineering to modulate antibody effector functions. by Wang X, Mathieu M, Brezski RJ. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5777978.txt.
Description
Wang, Mathieu, and Brezski review ways to engineer the Fc tail of IgG antibodies. Antibodies bind targets with one end and recruit immune action with the other. Most approved antibody drugs use the IgG1 subclass, which engages many immune parts. Small tail changes can tune that recruitment up or down.
The review sorts engineering efforts by their aim, from stronger killing to better safety. It explains how each change alters contact with immune components. Examples from clinical studies show the ideas at work in patients. The goal is antibody drugs that beat the natural isotype on both effect and safety.
Catalog record
| CREATOR | Wang X, Mathieu M, Brezski RJ. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |